Illumina, Inc. Independent Director Keith Meister sold a block of shares worth approximately $148 million.
The transaction was executed at a price of roughly $200 per share. This sale reduced Meister’s total holding in the genomics company by 26%.
The disposal marks the largest insider sale of Illumina shares in the past year. Investors frequently monitor significant insider trades for potential signals regarding a company's future performance.